Loading...
Jasper Therapeutics, Inc.
JSPRW•NASDAQ
Healthcare
Biotechnology
$0.13
$-0.01(-7.52%)
Jasper Therapeutics, Inc. (JSPRW) Financial Performance & Statements
Review Jasper Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-10.71%
↓ 10.71%
Net Income Growth
100.00%
↑ 100.00%
Operating Cash Flow Growth
-20.23%
↓ 20.23%
Operating Margin
-7067.21%
↓ 7067.21%
Gross Margin
24.53%
↑ 24.53%
Net Profit Margin
1169.34%
↑ 1169.34%
ROE
19.07%
↑ 19.07%
ROIC
-183.30%
↓ 183.30%
Jasper Therapeutics, Inc. (JSPRW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Jasper Therapeutics, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $48.80M | $71.64M | $92.50M | $106.82M |
| Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Cash & Short Term Investments | $48.80M | $71.64M | $92.50M | $106.82M |
| Net Receivables | $0.00 | $0.00 | $250000.00 | $250000.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Assets | $4.38M | $4.17M | $2.05M | $1.61M |
| Total Current Assets | $53.17M | $75.81M | $94.81M | $108.68M |
| Property Plant & Equipment (Net) | $3.47M | $2.85M | $3.18M | $3.67M |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill & Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Long Term Investments | $0.00 | $0.00 | $0.00 | $417000.00 |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $949000.00 | $1.24M | $1.43M | $1.16M |
| Total Non-Current Assets | $4.42M | $4.09M | $4.61M | $5.25M |
| Total Assets | $57.60M | $79.90M | $99.41M | $113.93M |
| Account Payables | $3.00M | $4.03M | $3.09M | $2.96M |
| Short Term Debt | $1.83M | $1.09M | $1.06M | $1.03M |
| Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Liabilities | $4.51M | $10.12M | $8.31M | $6.08M |
| Total Current Liabilities | $12.33M | $15.24M | $12.46M | $10.07M |
| Long Term Debt | $755000.00 | $0.00 | $1.01M | $1.29M |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $2.26M | $2.26M | $2.26M | $2.26M |
| Total Non-Current Liabilities | $3.02M | $2.99M | $3.27M | $1.29M |
| Capital Lease Obligations | $2.59M | $1.81M | $2.07M | $1.29M |
| Total Liabilities | $15.35M | $18.23M | $15.73M | $11.36M |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $2000.00 | $2000.00 | $2000.00 | $2000.00 |
| Retained Earnings | -$262.11M | -$240.87M | -$216.55M | -$197.91M |
| Accumulated Other Comprehensive Income/Loss | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Stockholders Equity | $42.24M | $61.67M | $83.68M | $100.31M |
| Total Equity | $0.00 | $61.67M | $83.68M | $100.31M |
| Total Liabilities & Stockholders Equity | $57.60M | $79.90M | $99.41M | $113.93M |
| Total Investments | $0.00 | $0.00 | $0.00 | $417000.00 |
| Total Debt | $2.59M | $1.81M | $2.07M | $2.32M |
| Net Debt | -$46.21M | -$69.82M | -$90.43M | -$104.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan